Quidel® Lyra
Influenza A+B Assay

for qualitative detection and identification

The Quidel® Lyra™ Influenza A+B Assay is a multiplex real-time PCR assay for the qualitative detection and identification of viral nucleic acids extracted from nasal swabs, nasopharyngeal swabs, and nasal aspirate/wash specimens. The assay is intended to aid in the differential diagnosis of influenza A and/or influenza B viral infections in humans. The assay has been shown to detect H1N1, H7N9, and H3N2 subtypes but does not differentiate the subtypes from influenza A.

Benefits of Quidel® Lyra™ Influenza A+B Assay

CE-IVD and IVD labeled
Detects over 50 strains of influenza including H1N1, H7N9, and H3N2
Yields up to 3% more positive A results and up to 6% more positive B results (resolved by sequencing) than a leading US molecular assay
Low inhibition (<1%) with robust internal control
Fewer false positives and false negatives than the leading competitor (0% compared to 0.5–1%)
Ordering information
Product Quantity Cat. No.

Quidel® Lyra™ Influenza A+B Assay
(For sale in the US and Europe only. The assay is validated for use on the QuantStudio® Dx and Applied Biosystems® 7500 Fast Dx Real-Time Instruments.)

96 reactions


Quidel® Lyra™ Influenza External Controls 10 reactions 4481148

Videos & webinars

More information